Trademark Details For ONCIRE (Serial Number 79188740)

  •  Home
  •  Print
ONCIRE
  • Rank
    Global Trademark Influence Ranking
    3398
3
32
11
3
word.basic_information
Serial Number  United States - USPTO 79188740
Registration Number 5070824
Mark
ONCIRE
Filing Date Jun-17-2016
Status
Dead  
CANCELLED – .. (709)
CANCELLED – SECTION 71
Attorney Name
TTAB
0
Action Tags
  


  • NOVARTIS


005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052





Correspondences

NameNovartis Pharma AG,
AddressTrademark Department Postfach CH-4002 Basel SWITZERLAND

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-18-2024TOTAL INVALIDATION PROCESSED BY THE IB   INNTP
Jan-29-2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB   INTSP
Jan-29-2024INVALIDATION PROCESSED   INPCP
Jan-12-2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED   INTRP
May-12-2023CANCELLED SECTION 71   C71TO
Dec-16-2016NOTIFICATION PROCESSED BY IB   GPNXP
Dec-01-2016FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Dec-01-2016FINAL DISPOSITION PROCESSED   FIMPP
Dec-01-2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB   GPARP
Nov-25-2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB   OPNXP
Nov-01-2016REGISTERED-PRINCIPAL REGISTER   R.PRA
Aug-16-2016PUBLISHED FOR OPPOSITION   PUBOA
Aug-10-2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB   OPNSP
Aug-10-2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB   OP2RP
Jul-27-2016NOTICE OF PUBLICATION   NPUBO
Jul-15-2016APPLICATION FILING RECEIPT MAILED   MAFRO
Jul-12-2016APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jul-11-2016ASSIGNED TO EXAMINER   DOCKD
Jul-11-2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jul-08-2016LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Jul-07-2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB   SDRCM